Does CABOTEGRAVIR Cause Injection site mass? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Injection site mass have been filed in association with CABOTEGRAVIR (Apretude). This represents 1.3% of all adverse event reports for CABOTEGRAVIR.
105
Reports of Injection site mass with CABOTEGRAVIR
1.3%
of all CABOTEGRAVIR reports
0
Deaths
4
Hospitalizations
How Dangerous Is Injection site mass From CABOTEGRAVIR?
Of the 105 reports, 4 (3.8%) required hospitalization.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR Cause?
Product dose omission issue (1,121)
Off label use (1,049)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which CABOTEGRAVIR Alternatives Have Lower Injection site mass Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL